In this clip from our 2022 mid-year update conference, Mark Moyad, MD, MPH asks Matthew Cooperberg, MD, MPH, about the use of Avodart (dutasteride) and Proscar (finasteride) in men on active surveillance. Dr. Cooperberg explains that the early belief that these medications increased the incidence of more aggressive prostate cancers was mistaken and that they actually only increased the detection rate of aggressive cancers by making PSA a more reliable indicator. Moreover, new data suggests that they decrease the rate of cancer progression for men on active surveillance; however, there are possible side effects and men should speak with their doctors as to whether these are good medications to consider while on active surveillance.
To see Dr. Cooperberg's faculty page, visit: [ Ссылка ]
To watch Dr. Cooperberg's full lecture and Q&A and the rest of the first day of our conference, which also featured Eugene Kwon, MD, on "Prostate Cancer Treatments and Imaging" and Jeffrey Brady, MD, on "Treatments for Incontinence," go to: [ Ссылка ]
To View Day 2, featuring Amar Kishan, MD on "Side Effects of Radiation Therapy," Nicholas J. Vogelzang, MD on "Advanced Treatment & Side Effects," and a conference wrap-up with Mark Scholz, MD, and Mark Moyad, MD, MPH, visit: [ Ссылка ]
Don’t know your stage? Take the quiz: Visit [ Ссылка ]
To learn more about prostate cancer, visit [ Ссылка ]
Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: [ Ссылка ]
Who we are:
The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs.
